Adia Nutrition (ADIA) EBT Margin (2025 - 2026)
Adia Nutrition's (ADIA) quarterly EBT Margin came in at 92.2% in Q1 2026, up 6975.0% year-over-year from 1.3% in Q1 2025, and up 43.07% quarter-over-quarter from 161.95% in Q1 2025.
Powered by 
Analysis
Adia Nutrition (ADIA) EBT Margin (2025 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported EBT Margin for 2 consecutive years, with 92.2% the latest figure, recorded in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | 55.43% |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | -885.91% |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | -49.02% |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | 14.32% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -1,356.24% |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | 36.51% |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | -24,299.18% |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | -0.44% |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 2.88% |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |